Table 4.
Comparing mortality rates between aspirin users (≥180 days) and non-users in patients (n = 333) with a subdivision of Stages III and IV NPC in the T category.
Stages III and IV a n = 333 | Low-Dose Aspirin | p-Value | ||
---|---|---|---|---|
Non-Users b n = 268 | Users ≥ 180 Days n = 65 | Aspirin Non-Users vs. User |
T1 and 2 vs. T3 and 4 | |
T1 and 2 | <0.001 *** | |||
Alive | 53 (62.4%) | 23 (88.5%) | 0.014 * | |
Dead due to NPC | 25 (29.4%) | 3 (11.5%) | ||
Other Causes of Dead | 7 (8.2%) | 0 (0.0%) | ||
T3 and 4 | ||||
Alive | 86 (47.0%) | 32 (82.1%) | <0.001 *** | |
Dead due to NPC | 71 (38.8%) | 4 (10.3%) | ||
Other Causes of Dead | 26 (14.2%) | 3 (7.7%) |
Abbreviation: vs. versus; a Stages IVa and IVb only; b One patient with missing data on T category of cancer; * p ≤ 0.05; *** p ≤ 0.001.